IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MERONI, PIERLUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.163
EU - Europa 24.548
AS - Asia 23.183
Continente sconosciuto - Info sul continente non disponibili 4.309
SA - Sud America 2.273
AF - Africa 419
OC - Oceania 87
Totale 79.982
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.028
GB - Regno Unito 8.279
CN - Cina 7.062
SG - Singapore 6.810
IT - Italia 4.248
RU - Federazione Russa 2.465
DE - Germania 2.320
SE - Svezia 1.911
HK - Hong Kong 1.890
VN - Vietnam 1.676
BD - Bangladesh 1.625
BR - Brasile 1.517
FR - Francia 1.277
TR - Turchia 1.014
IN - India 870
IE - Irlanda 825
KR - Corea 815
NL - Olanda 753
UA - Ucraina 733
CA - Canada 724
FI - Finlandia 614
EU - Europa 412
JP - Giappone 336
ID - Indonesia 290
CO - Colombia 281
ES - Italia 205
MX - Messico 203
PL - Polonia 190
AR - Argentina 181
GR - Grecia 111
IQ - Iraq 98
BE - Belgio 97
DK - Danimarca 93
CI - Costa d'Avorio 88
PH - Filippine 74
AT - Austria 72
ZA - Sudafrica 70
AU - Australia 69
EC - Ecuador 68
CL - Cile 67
CH - Svizzera 63
SA - Arabia Saudita 63
UZ - Uzbekistan 63
PK - Pakistan 60
TW - Taiwan 53
VE - Venezuela 53
IR - Iran 51
MY - Malesia 51
MA - Marocco 47
TH - Thailandia 42
EG - Egitto 39
RO - Romania 38
KE - Kenya 36
CR - Costa Rica 35
PT - Portogallo 35
PE - Perù 33
JM - Giamaica 28
NP - Nepal 28
TN - Tunisia 27
AE - Emirati Arabi Uniti 26
HN - Honduras 26
DZ - Algeria 25
UY - Uruguay 25
IL - Israele 24
PY - Paraguay 23
BO - Bolivia 21
RS - Serbia 21
JO - Giordania 20
OM - Oman 20
LT - Lituania 19
NO - Norvegia 19
PR - Porto Rico 19
CZ - Repubblica Ceca 18
BY - Bielorussia 17
HU - Ungheria 17
AL - Albania 16
BG - Bulgaria 16
HR - Croazia 16
NZ - Nuova Zelanda 16
TT - Trinidad e Tobago 15
ET - Etiopia 14
LU - Lussemburgo 14
AZ - Azerbaigian 13
KZ - Kazakistan 13
NI - Nicaragua 13
SV - El Salvador 13
DO - Repubblica Dominicana 12
NG - Nigeria 12
BB - Barbados 11
KG - Kirghizistan 11
LB - Libano 11
GT - Guatemala 10
PS - Palestinian Territory 10
GE - Georgia 9
SY - Repubblica araba siriana 9
KW - Kuwait 8
SK - Slovacchia (Repubblica Slovacca) 8
UG - Uganda 7
EE - Estonia 6
MD - Moldavia 6
Totale 75.935
Salva come PNG Salva come JPEG
Città #
Southend 7.635
Singapore 3.799
Ashburn 2.201
Hong Kong 1.766
Chandler 1.754
San Jose 1.552
Seattle 1.436
Beijing 1.333
Council Bluffs 1.170
Milan 1.125
Princeton 1.088
Santa Clara 976
Wilmington 858
Dallas 826
Dublin 808
Los Angeles 565
Ann Arbor 522
Redmond 518
Fairfield 474
Jacksonville 469
New York 465
Lauterbourg 463
Hangzhou 456
Bengaluru 428
Nanjing 428
Mountain View 426
Ho Chi Minh City 419
Des Moines 405
Moscow 385
Buffalo 374
Dearborn 367
Hanoi 357
Toronto 351
Frankfurt am Main 349
Hanover 349
Guangzhou 345
Sakarya 341
Boardman 319
Woodbridge 305
Shanghai 296
Houston 285
Rome 219
Serra 216
Bogotá 206
The Dalles 203
Redwood City 202
Somerville 195
Andover 191
Tokyo 186
Columbus 184
Hefei 178
Phoenix 168
Sunnyvale 167
Cangzhou 166
Jinan 166
Grafing 164
Tianjin 161
Dong Ket 160
Cambridge 151
Shenyang 147
Helsinki 144
São Paulo 132
Jakarta 126
Hebei 114
Shenzhen 113
Warsaw 113
Changsha 112
Munich 108
Eitensheim 106
Nanchang 102
Zhengzhou 88
Berlin 87
Abidjan 86
Chicago 86
Athens 84
Pisa 81
Seoul 80
Jiaxing 77
Da Nang 73
Brussels 68
San Diego 68
Turin 68
Fuzhou 67
Naples 65
London 61
Haiphong 60
Istanbul 57
Hamburg 56
Madrid 56
Montreal 54
Bitonto 53
Ottawa 53
Tashkent 53
Atlanta 51
Florence 50
Nuremberg 50
Wuhan 49
Kunming 48
Falls Church 47
Washington 47
Totale 45.311
Salva come PNG Salva come JPEG
Nome #
Management of Thrombotic Antiphospholipid Syndrome 784
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 773
The role of environmental estrogens and autoimmunity 642
The X chromosome and the sex ratio of autoimmunity 640
Complement activation in anti-phospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery 511
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) 487
Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases 477
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis 436
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 376
Inflammatory response and the endothelium 371
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade 371
X chromosome monosomy : a common mechanism for autoimmune diseases 370
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation 355
Antiphospholipid Antibodies and Infertility : A Gene Expression Study in Decidual Stromal Cells 355
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome 353
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 348
Cerebrospinal fluid phosphorylated neurofilament heavy chain and chitotriosidase in primary lateral sclerosis 327
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 326
mTOR as a multifunctional therapeutic target in HIV infection 325
Pidotimod : a reappraisal 309
Vitamin D and anti-phospholipid antibody syndrome : A comprehensive review 308
Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis : "Pros" and "Cons" 305
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome : evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients 301
X monosomy in female systemic lupus erythematosus 300
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers 293
Anti-beta 2 glycoprotein I antibodies in centenarians 292
The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies 287
Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1 : prevalence in systemic lupus erythematosus 283
Circulating stem cell factor in patients with chronic idiopathic urticaria 277
L’aumento del drive simpatico che si osserva durante bypass aortocoronarico correla con l’espressione delle citochine proinfiammatorie ed é attenuato dalla terapia betabloccante 273
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 272
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 271
Anti-inflammatory and immunosuppressive drugs and reproduction 263
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers 262
Complement activation in patients with COVID-19: a novel therapeutic target 262
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis : A EUSTAR analysis 260
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis 257
Primary biliary cirrhosis and Sjögren's syndrome : autoimmune epithelitis 256
Treatment of Thrombotic Antiphospholipid Syndrome : The Rationale of Current Management - An Insight into Future Approaches 255
Prolactin's role in the pathogenesis of the antiphospholipid syndrome 253
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus 248
Protective effect of a synthetic peptide mimicking the b2GPI PL-binding site on aPL-induced placental damage 244
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 243
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs : an Italian multicentre study 243
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients 242
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis 238
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide 237
Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 237
The geoepidemiology of autoimmune liver disease 230
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study 230
Patients with antiphospholipid syndrome display endothelial perturbation 229
IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus 227
Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss 225
Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects 223
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 223
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis : the interferon-inducible gene IFI16 222
Systemic Lupus erythematosus complicated by thrombotic thrombocytopenic purpura 218
The chemokine scavenger receptor D6 protects the fetus from inflammation-induced abortion 217
TLR-4 and Annexin A2 Involvement in endothelial cell activation by anti-phospholipid antibodies : specific silencing by small interfering RNAs 212
L’evoluzione da sindrome da anticorpi antifosfolipidi primaria a lupus eritematoso sistemico : possono gli anticorpi anti-nucleosomi essere predittivi? 211
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome 211
Lymphocyte markers and circulating immune complexes in primary glomerulonephritis 210
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 209
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in Chronic Fatigue Syndrome and Fibromyalgia but not in Depression: Preliminary report 208
Antiphospholipid antibodies and the antiphospholipid syndrome : pathogenic mechanisms 208
The Efficacy of Treatment with Low Dose Aspirin and Low Molecular Weight Heparin in Pregnant Women with Criteria Anti-Phospholipid Antibodies 208
Anti-DNA antibodies : a diagnostic and prognostic tool for systemic lupus erythematosus? 207
Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis : report of a family with multiple anti-phospholipid positive members 207
Increase of IgG-bearing peripheral blood lymphocytes and hypo IgG-globulinaemia in minimal change glomerulonephritis and focal glomerulosclerosis 206
Antiphospholipid antibodies and ex-vivo endothelial perturbation 205
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers 204
Up-date on the antiphospholipid syndrome 204
Association between clinical features and inflammatory gene SNPs in APS 204
Endothelium as a target for antiphospholipid antibodies 203
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor 203
Anti-phospholipid induced murine fetal loss : novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss 203
Mechanisms of action of antiphospholipid antibodies 202
Measuring IgA anti-β2-glycoprotein I and IgG/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome 202
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies 202
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2-glycoprotein i domain 1 and domain 4/5 : ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome 200
Toll-like receptors : another player in the pathogenesis of the anti-phospholipid sindrome 199
Anti-phospholipid antibody mediated fetal loss : still an open question from a pathogenic point of view 197
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study 196
Rheumatoid arthritis : a female challenge 196
Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies 196
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study 195
ANA screening : an old test with new recommendations 195
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block : an Italian multicentre cross-sectional study on behalf of the "Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group" 195
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 193
Anti-beta-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. 192
Sex and Management of Rheumatoid Arthritis 192
Assessment of musculoskeletal hand involvement in systemic sclerosis using ultrasonography and plain radiography 191
T cell defect in essential mixed cryoglobulinaemia 191
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination 191
Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century : A prospective multicenter study 190
Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies 190
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases 189
The role of superoxide anion generation in antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity 189
Hand impairment in systemic sclerosis : association of different hand indices with organ involvement 188
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 188
Totale 27.024
Salva come PNG Salva come JPEG
Categoria #
all - tutte 215.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.266 0 177 123 194 323 256 456 288 539 478 397 1.035
2022/20236.277 881 586 530 773 637 1.323 112 423 576 73 251 112
2023/20243.665 118 314 204 238 968 267 99 177 79 215 445 541
2024/20259.441 402 1.099 228 856 774 391 339 1.066 533 756 907 2.090
2025/202622.389 1.773 1.026 2.400 1.575 2.152 1.578 2.638 1.448 2.484 1.523 1.985 1.807
2026/20272.800 1.454 1.346 0 0 0 0 0 0 0 0 0 0
Totale 79.982